Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer

Mohamed El-Tanani, Shakta Mani Satyam, Sainath Prabhakar, Yahia El-Tanani, Ebrahim Safaii, Syed Arman Rabbani, Mark Sutherland · 2026

Read Dual targeting of EGFR signaling and microtubule dynamics enhances replication-associated cellular stress and suppresses tumor growth in gefitinib-resistant non-small cell lung cancer by Mohamed El-Tanani, Shakta Mani Satyam, Sainath Prabhakar, Yahia El-Tanani, Ebrahim Safaii, Syed Arman Rabbani, Mark Sutherland (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0360164.txt.

Description

Mohamed El-Tanani and colleagues reported in 2026 a two front strategy against lung cancers that have learned to resist the drug gefitinib. The cancer type is non-small cell lung cancer, and gefitinib works by blocking EGFR, a growth signal receptor many of these tumors depend on. Resistance to it is a common and deadly turning point.

The team combined EGFR blockade with a second attack on microtubules, the cell's internal scaffolding needed for division. Together, the two pressures raised the stress tied to copying DNA and suppressed tumor growth in their models. Combination strategies of this kind try to close the escape routes that single drugs leave open, and this study tests one pairing in detail.

Catalog record

CREATORMohamed El-Tanani, Shakta Mani Satyam, Sainath Prabhakar, Yahia El-Tanani, Ebrahim Safaii, Syed Arman Rabbani, Mark Sutherland
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67437
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0360164

Browse the full library · About the Tower of Babel